## MOH: Molina Healthcare, Inc. - XLV: Healthcare

### Executive Summary

STRENGTH thesis confirmed: MRS_20 at 9.7% in upper entry zone (4.0-10.0%), top 2% cross-sectional ranking. Short-term MRS_5 (5.2%) confirms momentum alignment. Strong momentum (+6.7% 5-day acceleration). Outperforming sector by 8.1%. Caution: overbought RSI (74).

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($167.24)
- **If Wrong:** Exit if MRS_20 drops below entry zone or breaks stop
- **Invalidation:** MRS_20 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 4
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. Molina Healthcare Stock Breaks Above Its 100-Day Moving Average as Michael Burry Pounds the Table on MOH**
- Source: Barchart.com | 20251231T190825 | Bullish | Relevance: 100%
- Molina Healthcare (MOH) shares recently closed higher after investor Michael Burry suggested the managed care firm could be a takeover target in 2026, citing its disciplined operations and profitability in Medicaid. The stock breaking above its 100-day moving average reinforces bullish sentiment. Even without a buyout, MOH is well-positioned to rally due to its focus on profitable operations and an attractive valuation of 0.22x sales.

**2. Stock Of The Day: Is Molina Healthcare About To Break Out?**
- Source: Benzinga | 20251231T172353 | Somewhat-Bullish | Relevance: 100%
- Molina Healthcare (NYSE: MOH) shares are trading quietly but are at a critical resistance level around $170.50. Historically, this level has acted as both support and resistance, with previous buyers who held losing positions now looking to sell at break-even. The article suggests that Molina is likely to either break through this resistance, leading to a potential uptrend, or reverse, as stocks tend not to remain at such levels for long.

**3. Molina Healthcare stock rises again after Michael Burry touts insurer; Feb. 5 earnings in focus**
- Source: ts2.tech | 20251231T155542 | Bullish | Relevance: 100%
- Molina Healthcare shares rose after investor Michael Burry compared the insurer to Berkshire Hathaway's Geico, sparking renewed interest. The stock's performance outpaced a softer healthcare sector, and investors are now keenly focused on the company's upcoming fourth-quarter and full-year earnings release on February 5, 2026, for signs of medical cost stabilization. Despite broader market weakness and cautious analyst recommendations, traders are watching if Molina can sustain its upward momentum.

**4. 12/30/2025 S&P 500 Update - Winners: AES, OXY, MOH - Losers: ARES, WSM, EPAM - S&P 500: -0.1%**
- Source: Trefis | 20251231T052254 | Bullish | Relevance: 74%
- This report provides a daily update for the S&P 500 performance on December 30, 2025, showing an overall decline of 0.1%. It highlights the top-performing stocks as AES, OXY, and MOH, while identifying ARES, WSM, and EPAM as the biggest losers for the day.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 1 ($0.05M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 61.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 11.9% (+0.1%)
- Capital World Invest: 9.5% (-2.0%)
- Blackrock Inc.: 8.4% (-3.9%)
- Price (T.Rowe) Assoc: 6.5% (+58.8%)
- AQR Capital Manageme: 5.4% (+217.0%)

### Key Risks

1. Elevated short interest (9.4%): bears positioning against stock.
2. Long-term trend broken: trading 20.3% below SMA200.
3. Falling knife pattern: rapid decline without stabilization, catch risk elevated.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_20 improving +6.7% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 2.54 signals overvaluation risk, limited margin of safety. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $9.7B |
| Beta | 0.52 |
| 52W Range | $133.40 - $359.97 |
| Short Interest | 9.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.54 |
| Forward P/E | 14.2 |
| Current P/E | 12.8 |
| YoY Growth | -10.1% |
| EPS Direction | None |

### Technicals

MRS_20 strengthening from 3.0% to 9.7% (+6.7% in 5 days), confirming momentum buildup. Currently in upper STRENGTH zone (4.0-10.0%), cross-sectional ranking at 98th percentile. MRS_5 at 5.2% confirms short-term momentum alignment. AM_20 at 9.1% shows strong absolute momentum above own 20MA. Outperforming sector by 8.1pp, stock-specific strength. Below SMA200 (0.80x), long-term trend not supportive. MACD histogram positive (1.48), confirming momentum. RSI overbought at 74, risk of mean reversion. OFD pattern: +STN (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 9.69% (CS: 98) | Strong |
| RSI_14 | 74.4 | Overbought |
| MACD Histogram | 1.48 | Bullish |
| vs SMA20 | 1.091x | Above |
| vs SMA50 | 1.151x | Above |
| vs SMA200 | 0.797x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $178.46
- **Stop Loss:** $167.24 (6.3% risk)
- **Target:** $195.29 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 128
- **Position Value:** $22,842.88
- **Portfolio %:** 22.84%
- **Risk Dollars:** $1,440.00
- **Risk Per Trade:** 1.44%
- **Modifiers:** L1 120% | L2 120% | Combined 1.44x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.20x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with stable risk appetite as 2026 trading begins. VIX at 14.51 (4th percentile) signals complacency while positive yield curve (+65bps) and moderate breadth (53.1%) support continuation. Focus on upcoming jobs data (Jan 9) and earnings season kickoff mid-January for directional catalysts.*

### Earnings

**Next:** 2026-02-04 (Est: $0.64)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $3.89 | $1.84 | -52.7% |
| 2025Q2 | $5.53 | $5.48 | -0.9% |
| 2025Q1 | $5.96 | $6.08 | +2.0% |
| 2024Q4 | $5.88 | $5.05 | -14.1% |

---
*RULE-based L3 | 2026-01-06 17:52 | MRS_20*